APA (7th ed.) Citation

Yen, Y., Tsau, T., Lee, C., Chen, H., Lin, C., Chen, T., & Pu, C. (2025). A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines. Dermatology & Therapy, 15(12), 3717. https://doi.org/10.1007/s13555-025-01561-5

Chicago Style (17th ed.) Citation

Yen, Yu-Hsiu, Tzu-Wen Tsau, Chih-Hung Lee, Hsin-Han Chen, Chih-Hung Lin, Tim-Mo Chen, and Chi-Ming Pu. "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines." Dermatology & Therapy 15, no. 12 (2025): 3717. https://doi.org/10.1007/s13555-025-01561-5.

MLA (9th ed.) Citation

Yen, Yu-Hsiu, et al. "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines." Dermatology & Therapy, vol. 15, no. 12, 2025, p. 3717, https://doi.org/10.1007/s13555-025-01561-5.